Is primary hyperoxaluria type 1 rare disease?
Primary hyperoxaluria type 1 (PH1) is a rare disorder that mainly affects the kidneys. It results from buildup of a substance called oxalate, which normally is filtered through the kidneys and excreted in the urine. In people with PH1, the accumulated oxalate is deposited in the kidneys and urinary tract.
What is PH2 disease?
Primary hyperoxaluria type 2 (PH2) is a condition where the body produces too much oxalate (oxalic acid). The extra oxalate combines with calcium to cause kidney stones, which can eventually lead to kidney damage and kidney failure. Damage to other organs, including bones and blood vessels, may also occur.
Who treats primary hyperoxaluria type 1?
The only cure for primary hyperoxaluria type 1 is a liver transplant. A transplanted liver from a healthy donor will make the enzymes your body needs to break down oxalate. Because PH1 often damages the kidneys, too, some people may need both a liver and kidney transplant.
Is primary hyperoxaluria curable?
There is no cure for primary hyperoxaluria. The goal is to protect the kidneys by preventing the development of kidney stones and prevent calcium oxalate from forming and depositing in other body tissues.
What is a hyperoxaluria?
Overview. Hyperoxaluria occurs when you have too much oxalate in your urine. Oxalate is a natural chemical in your body, and it’s also found in certain types of food. But too much oxalate in your urine can cause serious problems.
How is primary hyperoxaluria diagnosis?
Tests to diagnose hyperoxaluria may include: Urine tests, to measure oxalate and other metabolite levels in the urine. Blood tests, to show kidney function as well as oxalate levels in the blood. Stone analysis, to determine the composition of kidney stones passed or surgically removed.
What is the treatment for PH1?
Currently, the only curative treatment for PH1 is a liver transplant. If the patient has already progressed to kidney failure, then a dual liver/kidney transplant is required.
How common is PH1?
PH1 is an ultra-rare, inherited disease in which excessive amounts of oxalate are produced by the liver. PH1 affects approximately 4 individuals per million in the United States and Europe, with an estimated 1,300 to 2,100 diagnosed cases.
What is the difference between hyperoxaluria type 1 and Type 2?
In primary hyperoxaluria type 1, kidney stones typically begin to appear anytime from childhood to early adulthood, and ESRD can develop at any age. Primary hyperoxaluria type 2 is similar to type 1, but ESRD develops later in life.
What is the prevalence of primary hyperoxaluria?
It is estimated that about 5,000 patients in the United States have primary hyperoxaluria. Patients with primary hyperoxaluria typically develop kidney stones by the age of 20. If babies develop primary hyperoxaluria (rare), the condition tends to be severe.
What is the prognosis of hyperoxaluria type 2 (ESRD)?
While development of end-stage renal disease (ESRD) may be less common (and later occurring) in people with primary hyperoxaluria type 2 than in those with type 1, chronic and terminal renal insufficiency have been described. [5] [7] Prognosis depends on early treatment and management of hyperoxaluria and associated renal deterioration. [6]
Which genes cause primary hyperoxaluria?
Mutations in the AGXT, GRHPR, and HOGA1 genes cause primary hyperoxaluria types 1, 2, and 3, respectively. These genes provide instructions for making enzymes that are involved in the breakdown and processing of protein building blocks ( amino acids) and other compounds.